Bone Biologics Q3 EPS $(0.17) Beats $(0.18) Estimate

Benzinga · 1d ago
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 5.56 percent. This is a 54.05 percent increase over losses of $(0.37) per share from the same period last year.